Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Pantano

Showing results (81-90 of 130) with videos related to

Pageof 13
Sort By:
Frontiers in Oncology|February 28, 2022
The Role of the CDK4/6 Inhibitor Ribociclib in Locally Advanced and Oligometastatic Hormone Receptor Positive, Her2 Negative, Advanced Breast Cancer: Case Series and Review of the LiteratureAndrea Botticelli, Agnese Fabbri, Michela Roberto, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 29, 2020
Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samplesMarco Russano, Andrea Napolitano, Giulia Ribelli, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 26, 2020
Correction to: Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samplesMarco Russano, Andrea Napolitano, Giulia Ribelli, et al.
Cancer Research|July 26, 2018
miRNA-30 Family Members Inhibit Breast Cancer Invasion, Osteomimicry, and Bone Destruction by Directly Targeting Multiple Bone Metastasis-Associated GenesMartine Croset, Francesco Pantano, Casina W S Kan, et al.
Journal of Bone Oncology|November 7, 2022
Changes in bone turnover markers in patients without bone metastases receiving immune checkpoint inhibitors: An exploratory analysisFrancesco Pantano, Flavia Tramontana, Michele Iuliani, et al.
Oncology|December 17, 2013
Zoledronic acid induces a significant decrease of circulating endothelial cells and circulating endothelial precursor cells in the early prostate cancer neoadjuvant settingDaniele Santini, Alice Zoccoli, Chiara Gregorj, et al.
Clinical Medicine Insights. Oncology|August 22, 2020
Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality?Emanuela Dell'Aquila, Tea Zeppola, Marco Stellato, et al.
British Journal of Cancer|June 23, 2017
Human equilibrative nucleoside transporter 1 gene expression is associated with gemcitabine efficacy in advanced leiomyosarcoma and angiosarcomaBruno Vincenzi, Silvia Stacchiotti, Paola Collini, et al.
European Journal of Cancer (Oxford, England : 1990)|December 26, 2012
Dicer and Drosha expression and response to Bevacizumab-based therapy in advanced colorectal cancer patientsBruno Vincenzi, Alice Zoccoli, Gaia Schiavon, et al.
Oncotarget|April 19, 2015
Deregulation of dicer and mir-155 expression in liposarcomaBruno Vincenzi, Michele Iuliani, Alice Zoccoli, et al.
Pageof 13

Showing results (81-90 of 130) with videos related to

Sort By:
Pageof 13
Frontiers in Oncology|February 28, 2022
The Role of the CDK4/6 Inhibitor Ribociclib in Locally Advanced and Oligometastatic Hormone Receptor Positive, Her2 Negative, Advanced Breast Cancer: Case Series and Review of the LiteratureAndrea Botticelli, Agnese Fabbri, Michela Roberto, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 29, 2020
Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samplesMarco Russano, Andrea Napolitano, Giulia Ribelli, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 26, 2020
Correction to: Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samplesMarco Russano, Andrea Napolitano, Giulia Ribelli, et al.
Cancer Research|July 26, 2018
miRNA-30 Family Members Inhibit Breast Cancer Invasion, Osteomimicry, and Bone Destruction by Directly Targeting Multiple Bone Metastasis-Associated GenesMartine Croset, Francesco Pantano, Casina W S Kan, et al.
Journal of Bone Oncology|November 7, 2022
Changes in bone turnover markers in patients without bone metastases receiving immune checkpoint inhibitors: An exploratory analysisFrancesco Pantano, Flavia Tramontana, Michele Iuliani, et al.
Oncology|December 17, 2013
Zoledronic acid induces a significant decrease of circulating endothelial cells and circulating endothelial precursor cells in the early prostate cancer neoadjuvant settingDaniele Santini, Alice Zoccoli, Chiara Gregorj, et al.
Clinical Medicine Insights. Oncology|August 22, 2020
Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality?Emanuela Dell'Aquila, Tea Zeppola, Marco Stellato, et al.
British Journal of Cancer|June 23, 2017
Human equilibrative nucleoside transporter 1 gene expression is associated with gemcitabine efficacy in advanced leiomyosarcoma and angiosarcomaBruno Vincenzi, Silvia Stacchiotti, Paola Collini, et al.
European Journal of Cancer (Oxford, England : 1990)|December 26, 2012
Dicer and Drosha expression and response to Bevacizumab-based therapy in advanced colorectal cancer patientsBruno Vincenzi, Alice Zoccoli, Gaia Schiavon, et al.
Oncotarget|April 19, 2015
Deregulation of dicer and mir-155 expression in liposarcomaBruno Vincenzi, Michele Iuliani, Alice Zoccoli, et al.
Pageof 13